Transplantation of a liver with the C282Y mutation into a recipient heterozygous for H63D results in iron overload

American Journal of the Medical Sciences

Volumn 337, Issue 2, 2009, Pages 138-142

  Ismail, Mohammad K ^a,b,e   Martinez Hernandez, Antonio ^a,b   Schichman, Steven ^c,d   Chaudhry, Sufiyan ^b   Waters, Bradford ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c Central Arkansas Veterans Health Care System   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e NONE   (United States)

Author keywords

Hepcidin; Hereditary hemochromatosis; HFE mutation; Iron overload; Liver transplantation

Indexed keywords

GLIPIZIDE; HYPERIMMUNE GLOBULIN; LAMIVUDINE; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN; PRIMER DNA;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DIABETES MELLITUS; FOLLOW UP; GENE MUTATION; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS B; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LABORATORY TEST; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; DONOR; GENETICS; HEMOCHROMATOSIS; HETEROZYGOTE; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; POINT MUTATION; TIME;

BASE SEQUENCE; DNA PRIMERS; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; IRON OVERLOAD; LIVER TRANSPLANTATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POINT MUTATION; TIME FACTORS; TISSUE DONORS;

EID: 61849109810     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181719b4b     Document Type: Article

References (34)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408. (Pubitemid 26256612)
2. Lee PL, Gelbart T, West C, et al. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood cells Mol Dis 2001;27:783-802. (Pubitemid 33145024)
3. Beutler E, Felitti V, Gelbart T, et al. Genetics of iron storage and hemochromatosis. Drug Metab Dispos 2001;29:495-499
4. Bacon BR. Hemochromatosis: diagnosis and management. Gastroenterology 2001;120:718-725
5. Adams PC, Ghent CN, Grant DR, et al. Transplantation of a donor liver with haemochromatosis: evidence against an inherited intrahepatic defect. Gut 1991;32:1082-1083
6. Koskinas J, Portmann B, Lombard M, et al. Persistent iron overload 4 years after inadvertent transplantation of a haemochromatotic liver in a patient with primary biliary cirrhosis. J Hepatol 1992;16:351-354 (Pubitemid 23013229)
7. Dabkowski PL, Angus PW, Smallwood RA, et al. Site of principal metabolic defect in idiopathic haemochromatosis: insights from transplantation of an affected organ. BMJ 1993;306:1726.
8. Adams PC, Jeffrey G, Alanen K, et al. Transplantation of haemochromatosis liver and intestine into a normal recipient. Gut 1999;45:783. (Pubitemid 29492158)
9. Abdulkarim AS, Kim WR, Poterucha JJ, et al. Inadvertent transplantation of a hemochromatosis donor liver into a recipient with chronic hepatitic C. Am J Gastroenterol 2000;95:2556-2557
10. Wigg AJ, Harley H, Casey G. Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation. Gut 2003;52:433-435 (Pubitemid 36250067)
11. Prophet E, Millls B, Arrington J, et al. AFIP Laboratory Methods in Histotechnology. Washington DC: AFIP; 1994.
12. Merryweather-Clarke AT, Shearman JD, Robson KJ, et al. Hemochromatosis- related mutation detection. Blood 1998;91:2620-2621
13. Griffiths WJ, Kelly AL, Smith SJ, et al. Localization of iron transport and regulatory proteins in human cells. QJM 2000;93:575-587
14. Griffiths WJ, Sly WS, Cox TM. Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis. Gastroenterology 2001;120:1420-1429
15. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-7819 (Pubitemid 37385574)
16. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-8785 (Pubitemid 32678104)
17. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002;99:4596-4601 (Pubitemid 34286030)
18. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285:2216-2222 (Pubitemid 32416767)
19. Alanen KW, Chakrabarti S, Rawlins JJ, et al. Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors. Hepatology 1999;30:665-669 (Pubitemid 29409410)
20. Crawford DH, Fletcher LM, Hubscher SG, et al. Patient and graft survival after liver transplantation for hereditary hemochromatosis: implications for pathogenesis. Hepatology 2004;39:1655-1662 (Pubitemid 38702667)
21. Bralet MP, Duclos-Vallee JC, Castaing D, et al. Guettier C. No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis. Hepatology 2004;40:762.
22. Brunt EM, Olynyk JK, Britton RS, et al. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol 2000;95:1788-1793
23. Ganz T. Hepcidin in iron metabolism. Curr Opin Hematol 2004;11:251-254
24. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003;361:669-673
25. Gleeson F, Ryan E, Barrett S, et al. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis. Blood Cells Mol Dis 2007;38:37-44. (Pubitemid 44960862)
26. Piperno A, Girelli D, Nemeth E, et al. Blunted hepcidin response to oral iron challenge in HFE-hemochromatosis. Blood 2007;110:4096-4100 (Pubitemid 350248467)
27. Drakesmith H, Sweetland E, Schimanski L, et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc Natl Acad Sci USA 2002;99:15602-15607 (Pubitemid 35403979)
28. Montosi G, Paglia P, Garuti C, et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 2000;96:1125-1129 (Pubitemid 30616883)
29. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003;34:97-101. (Pubitemid 36548798)
30. Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol Dis 2003;30:288-297
31. Aguilar-Martinez P, Bismuth M, Picot MC, et al. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001;48:836-842
32. King C, Barton DE. Best practice guidelines for the molecular genetic diagnosis of type 1 (HFE-related) hereditary haemochromatosis. BMC Med Genet 2006;7:81.
33. Siah CW, Ombiga J, Adams LA, et al. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 2006;27:5-16.
34. Arya N, Chakrabrati S, Hegele RA, et al. HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors. Blood Cells Mol Dis 1999;25:354-357 (Pubitemid 30103956)